Cardiol Therapeutics Inc
TSX:CRDL
Cardiol Therapeutics Inc
TSX:CRDL
Price:
1.31
CAD
-7.09%
Market Closed
Market Cap:
CA$130.3m
Relative Value
The Relative Value of one
CRDL
stock under the Base Case scenario is
hidden
CAD.
Compared to the current market price of 1.31 CAD,
Cardiol Therapeutics Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
CRDL Relative Value
HIDDEN
Multiples Across Competitors
CRDL Competitors Multiples
Cardiol Therapeutics Inc Competitors
Cardiol Therapeutics Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
|
Cardiol Therapeutics Inc
TSX:CRDL
|
130.3m CAD | 0 | -3.7 | -3.3 | -3.3 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
997.2B USD | 15.3 | 48.3 | 32.5 | 34.6 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
578.6B USD | 6.1 | 21.6 | 15 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
282.3B CHF | 4.6 | 30 | 12.7 | 14.8 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
303.5B USD | 4.7 | 16.6 | 10.4 | 12.1 | |
| CH |
|
Novartis AG
SIX:NOVN
|
232.3B CHF | 5.3 | 21.3 | 13.2 | 16.9 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
220.2B GBP | 5.2 | 32.1 | 15.3 | 22.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.6 | 13.9 | 10.2 | 11.9 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.7B USD | 2.5 | 19.9 | 7.4 | 9.9 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
125.6B USD | 2.6 | 17.8 | 6.9 | 8.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
